Complete Remission With Imatinib in Metastatic Gastrointestinal Stromal Tumors
Matías ChacónEnrique RocaEduardo HuertasFernando Sánchez LoriaEnzo Domenichini
Metrics
Citation History
Topics
Related Documents
Retrospective study of complete remission imatinib-free metastatic gastro-intestinal stromal tumors (GIST).
Elise F. NassifLouise De ForcevilleArthur GéraudJustine GantzerCharles HonoréSarah DumontOlivier MirThierry de BaèreJean‐Yves BlayAxel Le Cesne
Complete remission of a metastatic gastrointestinal stromal tumour with the tyrosine kinase inhibitor imatinib (STI 571)
Christoph HögenauerCord LangnerRainer W. LippGerald HöflerGünter J. KrejsThomas Hinterleitner
The Efficacy of Imatinib in Unresectable/Metastatic Gastrointestinal Stromal Tumors
Shreyaskumar PatelPatrick WongTechnical Editor, Touch Briefings
Clonal Evolution of Resistance to Imatinib in Patients with Metastatic Gastrointestinal Stromal Tumors
Jayesh DesaiSridhar ShankarMichael C. HeinrichJonathan A. FletcherChristopher D.�M. FletcherJudi ManolaJeffrey A. MorganChristopher L. CorlessSuzanne GeorgeKemal TuncaliStuart G. SilvermanAnnick D. Van den AbbeeleEric van SonnenbergGeorge D. Demetri
Clinical prognostic factors in metastatic gastrointestinal stromal tumors (GIST) patients treated with Imatinib
Antonio López–PousaÓscar GallegoXavier Matías‐GuiuRosa NadalR Pinedo VillanuevaMiguel QuintanaGemma CarreraRaquel MarséVicenç ArtigasAgustí Barnadas